Related references
Note: Only part of the references are listed.Use of cannabis in the treatment of animals: a systematic review of randomized clinical trials
Tacio de Mendonca Lima et al.
ANIMAL HEALTH RESEARCH REVIEWS (2022)
Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs
Dakir Polidoro et al.
FRONTIERS IN VETERINARY SCIENCE (2022)
Safety and Efficacy of the Therapeutic Use of Cannabis-Based Products in the Treatment of Dogs: An Integrative Review
Diego Fontana de Andrade et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
Evaluation of the Effect of Cannabidiol on Naturally Occurring Osteoarthritis-Associated Pain: A Pilot Study in Dogs
Sebastian Mejia et al.
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION (2021)
Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs
Dana M. Vaughn et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2021)
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes
Giacomo Rossi et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2020)
Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders
Maria Fernandez-Trapero et al.
BIOMOLECULES (2020)
Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs
Dana Vaughn et al.
FRONTIERS IN VETERINARY SCIENCE (2020)
A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain
Chris D. Verrico et al.
PAIN (2020)
Oral Transmucosal Cannabidiol Oil Formulation as Part of a Multimodal Analgesic Regimen: Effects on Pain Relief and Quality of Life Improvement in Dogs Affected by Spontaneous Osteoarthritis
Federica Alessandra Brioschi et al.
ANIMALS (2020)
Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBDCannabisHerbal Extract in Dogs
Alan Chicoine et al.
FRONTIERS IN VETERINARY SCIENCE (2020)
Recovery of T-cell function in healthy dogs following cessation of oral cyclosporine administration
Lakshmi Narayanan et al.
VETERINARY MEDICINE AND SCIENCE (2020)
Immune Responses Regulated by Cannabidiol
James M. Nichols et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
A survey of veterinary student attitudes concerning whether marijuana could have therapeutic value for animals
Nadine A. Vogt et al.
PLOS ONE (2019)
Double blinded, vehicle controlled, crossover study on the efficacy of a topical endocannabinoid membrane transporter inhibitor in atopic Beagles
Rosanna Marsella et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2019)
The Endocannabinoid System of Animals
Robert J. Silver
ANIMALS (2019)
Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats
Kelly A. Deabold et al.
ANIMALS (2019)
US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions
Lori Kogan et al.
FRONTIERS IN VETERINARY SCIENCE (2019)
Localization of cannabinoid receptors CB1, CB2, GPR55, and PPAR alpha in the canine gastrointestinal tract
Giorgia Galiazzo et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2018)
The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and Intraspinal Spirocercosis
Jessica Freundt-Revilla et al.
PLOS ONE (2018)
Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs
Lauri-Jo Gamble et al.
FRONTIERS IN VETERINARY SCIENCE (2018)
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system
Jessica Freundt-Revilla et al.
PLOS ONE (2017)
Targeting Cannabinoid Signaling in the Immune System: High-ly Exciting Questions, Possibilities, and Challenges
Attila Olah et al.
FRONTIERS IN IMMUNOLOGY (2017)
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity
Xavier Nadal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
The use of cannabinoids in animals and therapeutic implications for veterinary medicine: a review
L. Landa et al.
VETERINARNI MEDICINA (2016)
Preferential epithelial expression of type-1 cannabinoid receptor (CB1R) in the developing canine embryo
Andrea Pirone et al.
SPRINGERPLUS (2015)
Identification of cannabinoid type 1 receptor in dog hair follicles
Francesca Mercati et al.
ACTA HISTOCHEMICA (2012)
Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis
Luca Campora et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2012)
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
Ewa Kozela et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Cloning and pharmacological characterization of the dog cannabinoid CB2 receptor
Christian Ndong et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol
Venkatesh L. Hegde et al.
PLOS ONE (2011)
Immunohistochemical localization of CB1 receptor in canine salivary glands
C. Dall'Aglio et al.
VETERINARY RESEARCH COMMUNICATIONS (2010)
Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: Involvement of regulatory T cells
Venkatesh L. Hegde et al.
MOLECULAR PHARMACOLOGY (2008)
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice
L Weiss et al.
AUTOIMMUNITY (2006)
Novel time-dependent vascular actions of Δ9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma
SE O'Sullivan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Examination of the immunosuppressive effect of Δ9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes
XG Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Share Paper
